Standard BioTools Inc (LAB)
2.48
-0.08
(-3.12%)
USD |
NASDAQ |
May 31, 16:00
2.475
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Revenue (Annual): 106.34M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 106.34M |
| December 31, 2022 | 97.95M |
| December 31, 2021 | 130.58M |
| December 31, 2020 | 138.14M |
| December 31, 2019 | 117.24M |
| December 31, 2018 | 112.96M |
| December 31, 2017 | 101.94M |
| December 31, 2016 | 104.45M |
| December 31, 2015 | 114.71M |
| Date | Value |
|---|---|
| December 31, 2014 | 116.46M |
| December 31, 2013 | 71.18M |
| December 31, 2012 | 52.33M |
| December 31, 2011 | 42.86M |
| December 31, 2010 | 33.56M |
| December 31, 2009 | 25.41M |
| December 31, 2008 | 15.35M |
| December 31, 2007 | 7.275M |
| December 31, 2006 | 6.398M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
97.95M
Minimum
2022
138.14M
Maximum
2020
118.05M
Average
117.24M
Median
2019
Revenue (Annual) Benchmarks
| Bruker Corp | 2.964B |
| Azenta Inc | 665.07M |
| Harvard Bioscience Inc | 112.25M |
| Bionano Genomics Inc | 36.12M |
| Akoya Biosciences Inc | 96.63M |